HIT Consultant – Read More

Prescribing has evolved into a financial decision as much as a clinical one. As a result, one of the most consequential access moments is now occurring inside the electronic health record (EHR) during the prescribing workflow, when cost information surfaces and treatment decisions are finalized. 

As affordability pressures intensify across commercial, Medicare, and Medicaid populations, patient out-of-pocket costs have become a primary driver of whether therapy is initiated or abandoned. Our recent survey of prescribers and technology leaders revealed how deeply the affordability discussion is influencing prescribing decisions. Pricing information is increasingly visible at the point of prescribing, yet fulfillment outcomes remain uncertain. That disconnect carries implications for adherence, pharmacy operations, and overall healthcare costs.

Prioritizing Cost Discussions

Medication cost is no longer a secondary consideration for patients. In the survey, 75% of prescribers report that potential out-of-pocket spending is a major or moderate barrier to patients starting or continuing therapy. Cost conversations are frequent: 77.2% of prescribers report being asked about medication expenses weekly or more often during patient visits.

These figures indicate that affordability pressures are now a structural feature of clinical care. Treatment selection increasingly depends on what patients, both with and without drug benefits, can afford in real time. When pricing is a concern for patients, either due to lack of coverage or high cost-sharing requirements, prescribers reported responding in numerous ways, such as searching for discount/cash options, exploring alternative medications, cancelling the prescription, or referring to the pharmacy.

These patterns point to the need for integrated, real-time comparison and alternative pricing options for patients with varying coverage levels, operating within existing prescribing workflows and providing closed-loop insight into whether prescriptions are ultimately filled. Such insight would certainly save prescribers time while improving patients’ access to needed medications.

Abandonment Persists

When affordability concerns are raised, more than half (54%) of prescribers report that patients very often or often fail to start prescribed medications, a finding that echoes a recent healthcare affordability report. Yet despite its importance, visibility into this cost-related abandonment is limited. Only 17.1% describe fulfillment data as “highly visible” in their current workflows.

As a result, prescriber insights into adherence behaviors are limited. Prescriptions are written with some level of price awareness, but few prescribers are certain that the patient paid that amount. 

In many organizations, non-covered scripts migrate into discount or cash pathways without comprehensive reporting back into clinical or benefit systems. That fragmentation makes it difficult to measure the true impact of affordability initiatives or to understand patient or health-plan member behavior across covered and non-covered channels.

Comparative Pricing Drives Confidence

Fortunately, most prescribers already receive some form of price information in their electronic prescribing workflow. In the survey, 77.1% report seeing medication pricing in the EHR. However, usefulness varies significantly depending on how that information is presented.

For example, 79% of prescribers rate pricing as useful when patient out-of-pocket costs for both insurance and discount options are visible together, compared with lower usefulness ratings for either pathway alone. Similarly, 94% say that viewing insurance-based and discount or cash pricing side by side would be extremely or very valuable.

These responses suggest that comparative visibility can be a powerful driver of adherence rather than a convenience feature, which means prescribers need clarity on which option is most likely to result in a filled prescription. A single price, even if accurate, does not fully answer that question when coverage restrictions, prior authorization requirements, or step-therapy barriers are present.

Overcoming Friction

When patients’ drug benefit plans indicate non-coverage or utilization management requirements, prescribers tend to seek immediate alternatives. In those scenarios, 63.6% report seeking a discount or a cash option. EHR workflow owners similarly observe that discounted or cash pricing is more often selected when both insurance and discount options are available.

This behavior reflects practical realities. Time constraints within the clinical encounter limit the ability to navigate complex benefit structures. Predictable pricing that can be acted on immediately often prevails over options that introduce uncertainty or delay.

For healthcare organizations, this trend underscores the importance of embedding affordability pathways directly into existing workflows. Real-time benefit pricing, along with configurable discount options, increases the likelihood that a prescription selected during the visit will be affordable and filled. When these capabilities can also route transactions through the most appropriate channel without requiring manual intervention, they help resolve cost concerns and save time within the existing workflow. 

From Visibility to Resolution

Survey results also show that price comparisons often occur outside the structured visit. Only 34.3% report that price comparison most often happens during the visit within the EHR. In many cases, staff follow up, or patients independently search for lower-cost options after the encounter.

Each additional handoff introduces friction. Delays increase the risk that prescriptions go unfilled. Fragmented workflows also complicate reporting, as prescriptions filled through discount networks may not be consistently captured in traditional benefit analytics.

A more resilient affordability strategy focuses on resolving cost questions at the point of prescribing and maintaining visibility through adjudication and reporting. 

For example, configurable comparison tools that present insurance copays alongside multiple eligible discount prices within a single view can help clarify the best available option in real time. At the same time, automated wrap capabilities that activate when medications are not covered can reduce manual overrides and minimize patient confusion. Behind the scenes, secure adjudication platforms and API-based integrations can support real-time decisioning while enabling closed-loop reporting across both covered and cash transactions.

Achieving Certainty

Given the increasing financial pressures facing patients, the objective for prescribers and EHR workflow owners is to move beyond price transparency toward cost certainty. Transparency informs decision-making, but certainty increases the likelihood of initiation. When affordability information is embedded within the prescribing and fulfillment journey, supported by enterprise-grade security and configurable logic, organizations gain clearer insight into patient behavior and stronger alignment between clinical intent and financial reality.

Affordability is already shaping therapy decisions and will likely continue to do so for the foreseeable future. The next phase of innovation in the prescribing journey will be to ensure that prescriptions written in the EHR are indeed filled and supported by the data infrastructure to understand and improve patient outcomes and experiences.

About Lathe Bigler
Lathe Bigler is SVP, Business Strategy of Buzz Health. Lathe Bigler is a seasoned healthcare technology executive with nearly three decades of experience driving strategic partnerships, clinical workflow innovation, and drug price transparency across digital health and e-prescribing ecosystems. He is currently leading strategic growth efforts at Buzz Health after steering mission-critical clinical network services and interoperability platforms in the industry.